The Association of Community Pharmacists of Nigeria (ACPN) is urging the federal government to invest in local drug production as a means of combating the HIV/AIDS epidemic. This appeal coincides with World HIV/AIDS Day and emphasizes the need to reduce dependence on external donors for prevention and treatment efforts.
According to ACPN National Chairman Pharmacist Ambrose Ezeh, Nigeria recorded an estimated 1,400 new HIV infections in 2023 alone. The recent reduction in funding support from the United States Government has heightened the urgency for decisive action by the federal government. Ezeh noted that, while Nigeria’s HIV response has historically been marked by resilience and innovation, a strengthened local commitment is now essential.
The ACPN chairman is advocating for government investment in the local manufacturing of antiretrovirals, diagnostic kits, and consumables. Such investment would ensure sustainability, safeguard uninterrupted service delivery, and reduce external dependency—critical factors in the fight against HIV/AIDS.
President Bola Ahmed Tinubu’s administration is being called upon to act immediately to address the HIV/AIDS crisis. The timing of the ACPN’s appeal is significant, given the substantial decline in external funding for HIV prevention and treatment in Nigeria. Prioritizing local production will help the country lessen its reliance on donors and enhance its capacity to respond effectively to the epidemic.
The World Health Organization (WHO) has stressed the importance of universal access to HIV prevention, treatment, and care. In Nigeria, this goal can be achieved by investing in domestic production of essential medicines and diagnostic tools, thereby strengthening healthcare infrastructure and improving services for those affected by HIV/AIDS.
The ACPN’s call to action serves as a reminder that a coordinated, sustained effort is needed to combat the HIV/AIDS epidemic in Nigeria.
Comments are closed for this story.